Measurement of the Compressive Strength of Concrete Using Modeling of Deep Hybrid Forest Regression

Autor: Rajprasad, J., Priya Rachel, P., Arulselvan, S., Arul, D., Ramesh Kumar, G., Pallavi, H. J., Sivaraja, M., Singh, Vinay Kumar, Gebreamlak, Getachew

Publikováno v: Advances in Materials Science and Engineering.

The paper proposes a deep hybrid forest regression-based modeling method for measuring the compressive strength (CS) of concrete. Then, the reduced feature vector is used as input to train multiple subforest models (SFM), the predicted values are sel

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=hindawi_publ::25289b9057aa62788b409c1b4fe5b3ca

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Rehabilitation of R.C.beams using natural fibre (Jute) reinforced polymer composites.

Autor: Poornima, J.¹, Sivaraja, M.²

Publikováno v: Journal of Intelligent & Fuzzy Systems. 2015, Vol. 28 Issue 1, p311-316. 6p.

The Influence of Nickel Oxide Nanoparticle Dispersion on the Thermo Stability of Lubricant Oil.

Autor: Ramachandran, K., Navaneethakrishnan, P., Sivaraja, M.

Publikováno v: International Journal of Nanoscience; Feb2020, Vol. 19 Issue 01, pN.PAG-N.PAG, 10p

VE-1902-A direct thrombin inhibitor with reversible covalent mechanism of action shows efficacy with reduced bleeding in rodent models of thrombosis.

Autor: Sivaraja M; Verseon Corporation, Fremont, CA, United States of America. Electronic address: msivaraja@verseon.com., Clemens DM; Verseon Corporation, Fremont, CA, United States of America., Sizikov S; Verseon Corporation, Fremont, CA, United States of America., Dash S; Verseon Corporation, Fremont, CA, United States of America., Xu C; Verseon Corporation, Fremont, CA, United States of America., Rienzo M; Verseon Corporation, Fremont, CA, United States of America., Yang B; Verseon Corporation, Fremont, CA, United States of America., Ryan M; Verseon Corporation, Fremont, CA, United States of America., Chattopadhyay M; Verseon Corporation, Fremont, CA, United States of America., Igoudin L; Verseon Corporation, Fremont, CA, United States of America., Chang SS; Verseon Corporation, Fremont, CA, United States of America., Keutzer S; Verseon Corporation, Fremont, CA, United States of America., Zalicki P; Verseon Corporation, Fremont, CA, United States of America., Estiarte MA; Verseon Corporation, Fremont, CA, United States of America., Shiau TP; Verseon Corporation, Fremont, CA, United States of America., Short KM; Verseon Corporation, Fremont, CA, United States of America., Williams DC; Verseon Corporation, Fremont, CA, United States of America., Datta A; Verseon Corporation, Fremont, CA, United States of America., Pozzi N; Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, MO, United States of America., Di Cera E; Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, MO, United States of America., Gibson CM; TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, United States of America., Fox KAA; Edinburgh Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom., Kita DB; Verseon Corporation, Fremont, CA, United States of America.

Publikováno v: Thrombosis research [Thromb Res] 2020 Jun; Vol. 190, pp. 112-121. Date of Electronic Publication: 2020 Apr 19.